Typhoid vaccine Vi polysaccharide - Bharat BiotechAlternative Names: TYPBAR; Typbar-Vi; Typhoid polysaccharide vaccine - Bharat Biotech; Vi capsular polysaccharide typhoid vaccine I.P. - Bharat Biotech
Latest Information Update: 27 Aug 2013
At a glance
- Originator Bharat Biotech
- Class Antibacterials; Bacterial vaccines; Polysaccharides
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Typhoid
Most Recent Events
- 17 Apr 2013 Launched for Typhoid (prevention) in Thailand (IM) before April 2013